Endonovo Therapeutics Inc (OTCQB:ENDV.PK)

0.6895
Delayed Data
As of Jun 30
 -0.1005 / -12.72%
Today’s Change
0.51
Today|||52-Week Range
3.50
-44.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

--
Revenue and IncomeNet Revenues30.6K22.9K24.2K--
 
 
 
 
Cost of Goods Sold--2.0K15.5K--
 
 
 
Depreciation And Amortization37.0K12.0K15.7K--
 
 
 
 
 
Operating ExpensesGross Income--8.9K-7.0K--
 
 
 
General Expenses1.7M2.4M2.2M--
 
 
 
 
Total Operating Expenses1.8M2.5M2.2M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.7M-2.4M-2.2M--
 
 
 
 
Extraordinary Charge-155.0K-197.8K0.00--
 
 
 
Interest Expense On Debt113.5K267.6K178.8K--
 
 
 
 
Other Expenses96.3K1.8K1.4M--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-2.9M-959.5K--
 
 
 
 
Income Taxes0.00-532.000.00--
 
 
Net Income-1.9M-2.9M-959.5K--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS481.4K697.3K30.3M--
 
 
 
 
Shares To Calculate EPS Diluted481.4K697.3K30.3M--
 
 
 
 
 
Earnings Per ShareEPS-$4.00-$4.00-$0.03--
 
 
 
 
EPS Diluted-$4.00-$4.00-$0.03--
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account